She focuses on translational/clinical research using targeted therapies to improve survival while decreasing treatment-related morbidiy/mortality in children with neuroblastoma. She started her research career in the lab of Dr. Timothy Cripe, MD, PhD in the Childhood Center for Cancer and Blood Disorders in the Research Institute of Nationwide Children's Hospital as a fellow in July 2012. She has presented her work at several national and international meetings involving the oncolytic HSV combined with 131I-mIBG therapy. Her research is funded by the Pediatric Cancer Foundation Sunshine Project and a new research project involving Unituxin is being funded by United Therapeutics.